Researchers reported in the journal Blood Advances that therapeutic phlebotomy and hydroxyurea are underutilized as treatments for elderly patients with polycythemia vera, despite being linked with reduced risk for thrombosis and improved overall survival. The retrospective study was based on data for 820 patients with a median age of 77 in the Surveillance, Epidemiology, and End Results-Medicare database.
Sign up for AABB SmartBrief
News about transfusion and cellular therapies
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.